Comorbidities and Healthcare Utilisation: Indicators for Improving COPD Diagnosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David B Price, MD
Research in Real-Life Ltd
Principal Investigator - Dermot Ryan, MBBS
University of Edinburgh
Study Director - Eric Bateman, MD
University of Cape Town
Study Director - Matt Kearney, MPH
Department of Health, United Kingdom
Study Director - Rupert Jones, MBBS
Peninsula College of Medinicne and Dentistry
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research in Real Life Ltd
Cambridge, Cambridgeshire, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2010
- Primary completion
- 28 Feb 2011
- Completion
- 30 Jun 2012
- Last update posted
- 2 Aug 2012
- Registered enrollment
- 38,859
- Registry id
- NCT01655667
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.